Anaplastic large-cell lymphoma with atypical chromosomal translocation t(2;5) and hypophyseal tumor

door Wang, Lei, Tong, Yin, Chen, Zhimei, Xu, Weilai, Jin, Jie
Gepubliceerd in 2010

Downregulation of hTERT: An Important As(2)O(3) Induced Mechanism of Apoptosis in Myelodysplastic Syndrome

door Xu, Weilai, Wang, Yungui, Tong, Hongyan, Qian, Wenbin, Jin, Jie
Gepubliceerd in PLoS One (2014)

Efficacy and safety of homoharringtonine plus cytarabine and aclarubicin for patients with myelodysplastic syndrome-RAEB

door XIAO, FENG, LI, YING, XU, WEILAI, YOU, LIANGSHUN, YANG, CHUNMEI, LIU, HUI, QIAN, WENBIN
Gepubliceerd in Oncol Lett (2016)

Acute myocardial/cerebral infarction as first/relapse manifestation in one acute promyelocytic leukemia patient

door Li, Ying, Suo, Shanshan, Mao, Liping, Wang, Lei, Yang, Chunmei, Xu, Weilai, Lou, Yinjun, Mai, Wenyuan
Gepubliceerd in Int J Clin Exp Med (2015)

Lower-dose decitabine improves clinical response compared with best supportive care in lower-risk MDS patients: a prospective, multicenter phase 2 study

door Ye, Li, Mei, Chen, Ren, Yanling, Zhou, Xinping, Ma, Liya, Xu, Weilai, Wei, Juying, Jiang, Huifang, Zhang, Liming, Zeng, Hui, Tong, Hongyan
Gepubliceerd in J Cancer (2021)

Real‐world data of chronic myelomonocytic leukemia: A chinese single‐center retrospective study

door Ma, Liya, Jiang, Lingxu, Yang, Wenli, Luo, Yingwan, Mei, Chen, Zhou, Xinping, Xu, Gaixiang, Xu, Weilai, Ye, Li, Ren, Yanlin, Lu, Chenxi, Lin, Peipei, Jin, Jie, Tong, Hongyan
Gepubliceerd in Cancer Med (2021)

Mutation status and burden can improve prognostic prediction of patients with lower‐risk myelodysplastic syndromes

door Jiang, Lingxu, Luo, Yingwan, Zhu, Shuanghong, Wang, Lu, Ma, Liya, Zhang, Hua, Shen, Chuying, Yang, Wenli, Ren, Yanling, Zhou, Xinping, Mei, Chen, Ye, Li, Xu, Weilai, Yang, Haiyang, Lu, Chenxi, Jin, Jie, Tong, Hongyan
Gepubliceerd in Cancer Sci (2019)

Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes

door Yan, Xuefen, Wang, Lu, Jiang, Lingxu, Luo, Yingwan, Lin, Peipei, Yang, Wenli, Ren, Yanling, Ma, Liya, Zhou, Xinping, Mei, Chen, Ye, Li, Xu, Gaixiang, Xu, Weilai, Yang, Haiyang, Lu, Chenxi, Jin, Jie, Tong, Hongyan
Gepubliceerd in Cancer Med (2021)

Impact of mutational variant allele frequency on prognosis in myelodysplastic syndromes

door Jiang, Lingxu, Wang, Lu, Shen, Chuying, Zhu, Shuanghong, Lang, Wei, Luo, Yingwan, Zhang, Hua, Yang, Wenli, Han, Yueyuan, Ma, Liya, Ren, Yanling, Zhou, Xinping, Mei, Chen, Ye, Li, Xu, Weilai, Yang, Haiyang, Lu, Chenxi, Jin, Jie, Tong, Hongyan
Gepubliceerd in Am J Cancer Res (2020)

Decitabine priming prior to low-dose chemotherapy improves patient outcomes in myelodysplastic syndromes-RAEB: a retrospective analysis vs. chemotherapy alone

door Ye, Li, Ren, Yanling, Zhou, Xinping, Mei, Chen, Ma, Liya, Ye, Xingnong, Wei, Juying, Xu, Weilai, Meng, Haitao, Qian, Wenbin, Mai, Wenyuan, Lou, Yinjun, Xu, Gaixiang, Qian, Jiejing, Lou, Yejiang, Luo, Yingwan, Xie, Lili, Lin, Peipei, Hu, Chao, Jin, Jie, Tong, Hongyan
Gepubliceerd in J Cancer Res Clin Oncol (2017)

The high NRF2 expression confers chemotherapy resistance partly through up-regulated DUSP1 in myelodysplastic syndromes

door Lin, Peipei, Ren, Yanling, Yan, Xiaomei, Luo, Yingwan, Zhang, Hua, Kesarwani, Meenu, Bu, Jiachen, Zhan, Di, Zhou, Yile, Tang, Yuting, Zhu, Shuanghong, Xu, Weilai, Zhou, Xinping, Mei, Chen, Ma, Liya, Ye, Li, Hu, Chao, Azam, Mohammad, Ding, Wei, Jin, Jie, Huang, Gang, Tong, Hongyan
Gepubliceerd in Haematologica (2019)